These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9509679)

  • 1. Visual field defects in patients with pituitary adenomas.
    Huang WC; Lee LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):245-51. PubMed ID: 9509679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
    Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
    World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for visual dysfunction in nonfunctioning pituitary adenomas - implications for neurosurgical management.
    Schmalisch K; Milian M; Schimitzek T; Lagrèze WA; Honegger J
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):728-34. PubMed ID: 22747829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
    Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
    AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
    Mejico LJ; Miller NR; Dong LM
    Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
    Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
    Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
    Monteiro ML; Zambon BK; Cunha LP
    Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
    Kim TG; Jin KH; Kang J
    Int Ophthalmol; 2019 Jan; 39(1):21-31. PubMed ID: 29274021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transsphenoidal Microneurosurgery. Part 4: Neuroophthalmological cure in pituitary adenoma].
    Oi S; Ciric IS
    No Shinkei Geka; 1982 Nov; 10(11):1183-7. PubMed ID: 7155292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiasma syndrome in acromegalic patients--correlation of neuroradiologic and neuroophthalmologic findings.
    Gnjidić Z; Iveković R; Rumboldt Z; Malenica M; Vizner B; Berković M
    Coll Antropol; 2002 Dec; 26(2):601-8. PubMed ID: 12528288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pituitary adenoma revealed by Traquair's syndrome].
    Candiloros H; Saudax E; George JL; Leclere J; Hartemann P
    Ann Endocrinol (Paris); 1992; 53(5-6):236-40. PubMed ID: 1340691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
    Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
    J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic presentation of pituitary adenoma.
    Baruffi DJ; Thompson KR
    Optom Vis Sci; 2012 Nov; 89(11):e56-64. PubMed ID: 23096493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
    Gedik S; Gur S; Atalay B; Colak M; Altinors N; Akova YA
    Saudi Med J; 2007 Sep; 28(9):1380-4. PubMed ID: 17768464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual disturbances in patients with pituitary adenoma.
    Ikeda H; Yoshimoto T
    Acta Neurol Scand; 1995 Aug; 92(2):157-60. PubMed ID: 7484065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scotomatous defects in the central visual field in pituitary adenomas.
    Sugita K; Sato O; Hirota T; Tsugane R; Kageyama N
    Neurochirurgia (Stuttg); 1975 Sep; 18(5):155-62. PubMed ID: 172816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions.
    Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H
    J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
    Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
    World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of optical coherence tomography in the detection of pituitary adenoma.
    Johansson C; Lindblom B
    Acta Ophthalmol; 2009 Nov; 87(7):776-9. PubMed ID: 18771481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
    Hajiabadi M; Alimohamadi M; Fahlbusch R
    World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.